Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

March 17, 2015November 9, 2015

Quadriceps Endurance is Reduced in Individuals with COPD

COPD, News

Findings from a recent study indicate that quadriceps endurance is reduced in individuals with Chronic Obstructive Pulmonary Disease (COPD) in comparison to healthy people, independent of the type of task ... Read more

March 16, 2015November 5, 2015

Creon® Micro Effective in CF-Related Pediatric Exocrine Pancreatic Insufficiency

Cystic Fibrosis, News

Findings from a recent study published in the Journal of Cystic Fibrosis revealed that pancreatin (Creon Micro) is an effective treatment for children with exocrine pancreatic insufficiency caused by cystic ... Read more

March 12, 2015November 6, 2015

Airway Lumen is Reduced in Asthmatic Smokers, According to Study

Asthma, News

According to a recent study published in the journal Chest, the Official Journal of the American College of Chest Physicians found that compared to people with asthma who never smoked, the CT scan ... Read more

March 10, 2015November 5, 2015

Allicin-Containing Garlic Extracts Could Fight Infections in Cystic Fibrosis

Cystic Fibrosis, News

Results from a recent study published in the journal PLoS One shows evidence that allicin, a substance found in garlic extracts, possesses inhibitory and bactericidal properties against life-threatening lung infections in ... Read more

March 6, 2015November 9, 2015

Majority of COPD Patients Do Not Receive Maintenance Treatment, Study Shows

COPD, News

A majority of patients with COPD receive maintenance medications, but less than half receive guideline-recommended care, especially those with an exacerbation history. This is according to a new study published in the International Journal ... Read more

March 5, 2015November 6, 2015

Reslizumab Reduces Risk of Severe Asthma Exacerbations

Asthma, News

Results from two multi center clinical trials support the use of reslizumab in patients with asthma and elevated blood eosinophil counts who are inadequately controlled on inhaled corticosteroid-based therapy. The ... Read more

March 3, 2015November 6, 2015

Handheld Device Can Diagnose Asthma With One Drop of Blood

Asthma, News

A team of researchers funded by the National Institute of Biomedical Imaging and Bioengineering led by David Beebe, Ph.D., Director of the Microtechnology, Medicine, and Biology lab at the University of ... Read more

March 2, 2015November 9, 2015

Enhancing and Inhibiting Autophagy in Lung Disease is Double-Edged

COPD, News

Researchers from the Weill Cornell Medical College and New York-Presbyterian Hospital in New York recently discussed the role of autophagy in lung diseases in a study titled “Autophagy in lung disease pathogenesis ... Read more

February 20, 2015November 5, 2015

Azithromycin Can Help Control Cystic Fibrosis Exacerbations

Cystic Fibrosis, News

According to a recent review published in the European Journal of Clinical Microbiology & Infectious Diseases, azithromycin is an effective drug for patients with Cystic Fibrosis suffering from P. aeruginosa infections. ... Read more

February 19, 2015November 5, 2015

Biotie’s Experimental Drug for Inflammatory, Fibrotic Pulmonary Diseases Receives Positive Feedback

Idiopathic Pulmonary Fibrosis, News

Biotie’s BTT1023 drug recently received positive feedback regarding Orphan Drug Designation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA). BTT1023 is an experimental therapy indicated for ... Read more